Treatment of serous macular retinal detachment with antihistamines

被引:0
|
作者
Kirschfeld, K. [1 ]
机构
[1] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany
来源
OPHTHALMOLOGE | 2015年 / 112卷 / 01期
关键词
Central serous retinopathy; Macular degeneration; Histamine; Antihistamines; Mineral corticoid receptor antagonists;
D O I
10.1007/s00347-014-3096-y
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The etiology of retinal detachment in central serous retinopathy (CSR) is unknown; however, three facts are generally accepted: (1) the serous exudate which raises the layers of the receptors/pigment epithelium is formed due to hyperpermeability in the choriocapillaries, (2) patients frequently suffer from headaches and (3) stress promotes the incidence of CSR. A high blood plasma histamine concentration can cause the abovementioned symptoms which suggests that histamine might provoke CSR. Within 1 week after administration of the antihistamine loratadin a considerable reduction in the retinal exudate and restoration of vision were observed. This supports the hypothesis that histamine could be involved in the process of retinal detachment. Further investigations and large scale clinical trials should clarify if this hypothesis can be proved or disproved and whether antihistamines can be used for age-related macular degeneration (AMD).
引用
收藏
页码:57 / 60
页数:4
相关论文
共 50 条
  • [1] Antihistamines for the Treatment of serous macular Retinal Detachment
    Hassenstein, A.
    [J]. OPHTHALMOLOGE, 2016, 113 (12): : 1088 - 1088
  • [2] Treatment Outcomes in Uveitic Macular Edema with Serous Retinal Detachment
    Huddleston, Stephen
    Houser, Kourtney
    Bennett, Daniel
    Walton, R. Christopher
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [3] Impact of serous macular detachment on visual recovery in retinal vein occlusion treatment
    Firat, Ilknur Tuncer
    Polat, Nihat
    Firat, Murat
    [J]. ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2022, 85 (06) : 606 - 613
  • [4] Intravitreal bevacizumab for treatment of serous macular detachment in central retinal vein occlusion
    Cinal, Adnan
    Ziemssen, Focke
    Bartz-Schmidt, Karl U.
    Gelisken, Faik
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 249 (04) : 513 - 520
  • [5] Intravitreal bevacizumab for treatment of serous macular detachment in central retinal vein occlusion
    Adnan Cinal
    Focke Ziemssen
    Karl U. Bartz-Schmidt
    Faik Gelisken
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2011, 249 : 513 - 520
  • [6] Influence of serous retinal detachment on the outcome of ranibizumab treatment in diabetic macular oedema
    Ercalik, Nimet Yesim
    Imamoglu, Serhat
    Kumral, Esra Turkseven
    Yenerel, Nursal Melda
    Bardak, Handan
    Bardak, Yavuz
    [J]. CUTANEOUS AND OCULAR TOXICOLOGY, 2018, 37 (04) : 324 - 327
  • [7] Serous Macular Detachment Associated with Retinal Arterial Macroaneurysm
    Kyoichi Takahashi
    Shoji Kishi
    [J]. Japanese Journal of Ophthalmology, 2006, 50 : 460 - 464
  • [8] Serous macular detachment in central retinal vein occlusion
    Ozdemir, H
    Karacorlu, M
    Karacorlu, S
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2005, 25 (05): : 561 - 563
  • [9] Serous macular detachment associated with retinal arterial macroaneurysm
    Takahashi, Kyoichi
    Kishi, Shoji
    [J]. JAPANESE JOURNAL OF OPHTHALMOLOGY, 2006, 50 (05) : 460 - 464
  • [10] Is Histamine Involved in the Formation of serous macular Retinal Detachment?
    Kirschfeld, K.
    [J]. OPHTHALMOLOGE, 2016, 113 (12): : 1089 - 1090